A Glass of Water Immediately Increases Gastric pH in Healthy Subjects

被引:20
作者
Karamanolis, George [2 ]
Theofanidou, Ioanna [2 ]
Yiasemidou, Marina [2 ]
Giannoulis, Evangelos [2 ]
Triantafyllou, Konstantinos [2 ]
Ladas, Spiros D. [1 ]
机构
[1] Univ Athens, Hepatogastroenteroly Unit, Dept Internal Med Propaedeut 1, Laikon Gen Hosp, Athens 11527, Greece
[2] Univ Athens, Hepatogastroenteroly Unit, Dept Internal Med Propaedeut 2, Attikon Univ Gen Hosp, Athens 11527, Greece
关键词
Water antacids; PPIs; Ranitidine; Gastric pH; Onset of action;
D O I
10.1007/s10620-008-0301-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Onset of action of antisecretory agents is of pivotal importance for patients with gastroesophageal reflux disease (GERD) treated "on-demand." Aim To study the acute effect of acid-inhibiting drugs and water administration on gastric pH. Method A cross-over study was performed in 12 H. pylori (-), healthy subjects (6 men; mean age: 26 years). A single oral dose of the following agents was received with a wash-out period between each study: a glass of water (200 ml), antacid, ranitidine, omeprazole, esomeprazole, and rabeprazole. Gastric pH was recorded for 6 h after drug intake. Results Water increased gastric pH > 4 in 10/12 subjects after 1 min. The time (median) needed to pH > 4 was for: antacid 2 min, ranitidine 50 min, omeprazole 171 min, esomeprazole 151 min, and rabeprazole 175 min. Gastric pH > 4 lasted for 3 min after water and for 12 min after antacids; it remained > 4 until the end of recording in: 4/12 subjects with ranitidine, 11/12 with rabeprazole, and all with omeprazole and esomeprazole. Conclusion Water and antacid immediately increased gastric pH, while PPIs showed a delayed but prolonged effect compared to ranitidine.
引用
收藏
页码:3128 / 3132
页数:5
相关论文
共 18 条
[1]   The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH [J].
Abe, Y ;
Inamori, M ;
Togawa, J ;
Kikuchi, T ;
Muramatsu, K ;
Chiguchi, G ;
Kawamura, H ;
Kobayashi, N ;
Kirikoshi, H ;
Sakaguchi, T ;
Takamura, T ;
Nakajima, A ;
Ueno, N ;
Sekihara, H .
JOURNAL OF GASTROENTEROLOGY, 2004, 39 (01) :21-25
[2]   In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity [J].
Arnestad, JS ;
Kleveland, PM ;
Waldum, HL .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) :355-358
[3]   APPROPRIATE ACID SUPPRESSION FOR THE MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE [J].
BELL, NJV ;
BURGET, D ;
HOWDEN, CW ;
WILKINSON, J ;
HUNT, RH .
DIGESTION, 1992, 51 :59-67
[4]   Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole [J].
Carlsson, R ;
Dent, J ;
Watts, R ;
Riley, S ;
Sheikh, R ;
Hatlebakk, J ;
Haug, K ;
de Groot, G ;
van Oudvorst, A ;
Dalvag, A ;
Junghard, O ;
Wiklund, I .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (02) :119-124
[5]   The comparative effects of single intravenous doses of cimetidine, ranitidine, famotidine, and omeprazole on intragastric pH [J].
Chassany, O ;
Bergmann, JF ;
Simoneau, G ;
ElouaerBlanc, L ;
Segrestaa, JM ;
Caulin, C .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (03) :159-167
[6]  
Fass R, 2001, AM J GASTROENTEROL, V96, P303
[7]   On-demand therapy for gastroesophageal reflux disease: Are current proton pump inhibitors good candidates? [J].
Goh, Khean-Lee .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 :S115-S118
[8]   Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease [J].
Hatlebakk, JG ;
Berstad, A .
CLINICAL PHARMACOKINETICS, 1996, 31 (05) :386-406
[9]   Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers [J].
Hedenstrom, H ;
Alm, C ;
Kraft, M ;
Grahnen, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (06) :1137-1141
[10]   COMPARISON OF ACID INHIBITION BY EITHER ORAL HIGH-DOSE RANITIDINE OR OMEPRAZOLE [J].
HURLIMANN, S ;
ABBUHL, B ;
INAUEN, W ;
HALTER, F .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1994, 8 (02) :193-201